Valuation : JBCHEMICAPAR

Market Cap 387B 4.08B 3.52B 3.31B 3.02B 5.67B 5.7B 39.15B 15.24B 197B 15.32B 14.99B 653B P/E 2027 *
43.3x
P/E 2028 * 33x
Enterprise Value 387B 4.08B 3.52B 3.31B 3.02B 5.67B 5.7B 39.15B 15.24B 197B 15.32B 14.99B 653B EV / Sales 2027 *
8.14x
EV / Sales 2028 * 7.12x
Free-Float
-
Yield 2027 *
0.72%
Yield 2028 * 0.86%
1 day-3.73%
3 months+12.69%
6 months+17.50%
Current year+32.51%
Current year 1,777.05
Extreme 1777.05
2,509.4
1 year 1,603.05
Extreme 1603.05
2,509.4
3 years 1,246.05
Extreme 1246.05
2,509.4
5 years 669.52
Extreme 669.525
2,509.4
10 years 118
Extreme 118
2,509.4
Date Insider Type Main position Quantity % Market Cap. Importance
22/9/25 Sell

Chief Executive Officer

24,785 0.0159%
22/9/25 Sell

Chief Executive Officer

19,312 0.0124%
15/9/25 Sell

Chief Executive Officer

965 0.0006%

Financials

2027 *2028 *
Net sales 47.6B 502M 433M 407M 371M 697M 701M 4.81B 1.87B 24.22B 1.88B 1.84B 80.29B 54.41B 573M 495M 465M 424M 797M 801M 5.5B 2.14B 27.68B 2.15B 2.11B 91.77B
Net income 9B 94.8M 81.78M 76.92M 70.08M 132M 132M 909M 354M 4.58B 356M 348M 15.18B 11.85B 125M 108M 101M 92.33M 174M 175M 1.2B 466M 6.03B 469M 459M 19.99B
Net Debt - -
Logo JBCHEMICAPAR
J.B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company specializes in gastroenterology, hypertension and dermatology. It is also focused on other therapeutic categories like nephrology, respiratory, virology, diabetes, and nicotine replacement therapy (NRT). The Company is engaged in the business of manufacturing and marketing of a diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). Its brands include Nicardia, Cilacar, Rantac, Metrogyl, and Cilacar-T. It specializes in manufacturing medicated and herbal lozenges. It produces hard-candy lozenges, soft-center lozenges and powder-filled lozenges for varied medical needs. Its API products include Diclofenac Sodium, Diclofenac Diethylamine, Diclofenac Acid, Nifedipine, and others. It maintains a direct presence in Russia and South Africa, while leveraging distributor partnerships across the United States, Asia, Africa, and Latin America.
Employees
5,602
Sector
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
2,412.25INR
Average target price
2,328.14INR
Spread / Average Target
-3.49%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. JBCHEPHARM Stock